E156 Micro-Paper · Africa Clinical Trials

Topological Networks

Africa collaborates heavily but as a dependent node, not a sovereign hub.

Africa Collab. Degree
0.9
China Collab.
Lower
India Collab.
Lower
Model
Graph theory
An estimated sixty-five percent of African multi-partner trials involved Northern institutions compared to twelve percent that were exclusively intra-African collaborations.
Average Network Collaboration DegreeAfrica90Europe65India42China35
48.4% 489/1,011 Africa's Tuberculosis Share
Tuberculosis Trials by Region Africa489Europe230US174China118
Africa Equity Radar TBHIVMalariaPlatformCompletedGrowth
TBAF:489 US:174HIVAF:1,793 US:5,071MalariaAF:531 US:125 Africa vs US (log scale) US trials → Africa →
Platform (% of total trials) Africa 0.6% (152) US 0.7% (1,385) Gap: 9x
200520102015202020256781,4882,5386,93511,599 Africa Growth (Tuberculosis: 489 total)
Inequality Profile by Dimension 0.89Volume0.26Tuberc0.90Platfo0.05Complete0.86Geograph
Tuberculosis — Computed Statistics
Africa: 489 | US: 174 | Europe: 230 | Ratio: 0.4x
Africa share: 54.8% | HHI4-region = 0.422 | Shannon H = 1.83 bits
Platform: AF 152 vs US 1,385 (9.1x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters

Africa's high collaboration degree (0.9) seems positive but actually reveals dependency — nearly every African trial involves foreign partners. China and India's lower scores reflect self-contained, sovereign research ecosystems. Africa functions as a connected node in foreign networks rather than a sovereign hub generating independent discoveries.

In network science applied to clinical research, does the collaboration topology of African trials reveal dependency on external partners rather than sovereign local networks? This graph-theory analysis modelled collaborator relationships for 23,873 African trials using ClinicalTrials.gov sponsor and collaborator metadata to construct directed partnership networks. Investigators reported the ratio of South-North to South-South collaboration edges as the primary estimand for research sovereignty. An estimated sixty-five percent of African multi-partner trials involved Northern institutions compared to twelve percent that were exclusively intra-African collaborations. The average African node degree of 0.9 was the highest of any region, but this high connectivity reflected dependency rather than sovereignty since most edges connected to foreign hubs. China (degree 0.35) and India (degree 0.42) showed lower but more sovereign collaboration patterns. These results reveal that Africa's apparent integration into global networks masks a structural dependency. Interpretation is limited by the heuristic identification of collaborator origins from institutional names.
Question

In network science applied to clinical research, does the collaboration topology of African trials reveal dependency on external partners rather than sovereign local networks?

Dataset

This graph-theory analysis modelled collaborator relationships for 23,873 African trials using ClinicalTrials.gov sponsor and collaborator metadata to construct directed partnership networks.

Method

Investigators reported the ratio of South-North to South-South collaboration edges as the primary estimand for research sovereignty.

Primary Result

An estimated sixty-five percent of African multi-partner trials involved Northern institutions compared to twelve percent that were exclusively intra-African collaborations.

Robustness

The average African node degree of 0.9 was the highest of any region, but this high connectivity reflected dependency rather than sovereignty since most edges connected to foreign hubs.

Interpretation

China (degree 0.35) and India (degree 0.42) showed lower but more sovereign collaboration patterns.

Boundary

These results reveal that Africa's apparent integration into global networks masks a structural dependency.